logo
Plus   Neg
Share
Email

Stock Alert: Chegg Gains As More Turn To Online Education

Education technology company Chegg, Inc. (CHGG) is one of the biggest gainers in the recent months with more than 140% surge in stock within three months.

Chegg offers online tutoring, rental, and sale of digital as well as physical textbooks, and other student services including helping them obtain grants and loans among other things.

Online education platforms have picked up popularity more than ever these days as educational institutions are closed due to coronavirus pandemic.

While talking to analysts during the first-quarter earnings call, Dan Rosensweig, Co-Chairperson and Chief Executive Officer of the company commented, " As we think about the lasting impact on the future of higher education globally, we see these trends continuing."

Early this month, when the company reported first-quarter results, revenue had grown 35% year-over-year to $131.6 million, driven by subscriber growth of 35%. Earnings of $0.22 per share beat the average estimate of analysts polled by Thomson Reuters at $0.15.

For the second quarter, the company's revenue outlook of $135 million - $137 million remains above the consensus estimate of $123.81 million. Chegg sees subscriber growth to be more than 45% for the period.

Friday, Chegg stock was up $1.36 or 2.08% before closing at $66.66.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT